4//SEC Filing
Shan Joseph 4
Accession 0001019687-10-000394
CIK 0000704562other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:04 PM ET
Size
8.1 KB
Accession
0001019687-10-000394
Insider Transaction Report
Form 4
Shan Joseph
VP Clin./Regulatory Affs. (3)
Transactions
- Award
Common Stock, $.001 par value
2010-02-01+25,000→ 25,436 total - Award
Incentive Stock Option (right to buy)
2010-02-01+75,000→ 154,645 totalExercise: $2.93Exp: 2020-02-01→ Common Stock (75,000 underlying)
Footnotes (4)
- [F1]These performance-based restricted shares were issued pursuant to a Stock Issuance Agreement dated February 1, 2010 and are subject to a vesting requirement based upon the timely attainment of certain predetermined clinical, financial and operational milestones. In this regard, 20% of the performance-based restricted shares will vest upon the attainment of each predetermined milestone, which have targeted completion dates ranging from June 30, 2010 through July 15, 2011.
- [F2]Includes performance-based restricted shares issued pursuant to a Stock Issuance Agreement dated February 1, 2010.
- [F3]Option will vest quarterly in equal installments over a two year period.
- [F4]n/a
Documents
Issuer
PEREGRINE PHARMACEUTICALS INC
CIK 0000704562
Entity typeother
Related Parties
1- filerCIK 0001457697
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 5:04 PM ET
- Size
- 8.1 KB